IMAX

IMAX Corporation
$39.12
+5.24 (+15.47%)
Mkt Cap 2.15B
Volume 3,662,131
52W Range 24.2-43.16
Sector Communication Services
Beta 0.36
EPS (TTM) 0.68
P/E Ratio 57.54
Revenue (TTM) 404.92M
Rev Growth (5Y) +24.5%
EPS Growth (5Y) +4.7%
AlphaVal · Fair Value
$42.25
Fair Value · Mild
7.4% below fair value
AlphaQuality · Grade · Gated
F
Platform & Compounding FCF
30.0 / 100 pillar composite (overridden)

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 410.21M 352.21M 374.84M 300.81M 254.88M 137.00M 395.66M 374.40M 380.77M 377.33M 373.81M 290.54M
Net Income 34.88M 26.06M 25.34M (22.80M) (22.33M) (143.78M) 46.87M 22.84M 2.34M 28.79M 55.84M 39.74M
EPS 0.65 0.49 0.47 -0.40 -0.38 -2.43 0.76 0.36 0.04 0.43 0.79 0.58
Free Cash Flow 118.90M 29.62M 25.78M (15.30M) (11.71M) (32.27M) 39.53M 53.10M 13.38M 14.90M N/A N/A
FCF / Share 2.22 0.56 0.47 -0.27 -0.20 -0.54 0.64 0.84 0.20 0.22 N/A N/A
Operating CF 127.07M 70.84M 58.62M 17.32M 6.07M (23.01M) 90.38M 109.97M 85.37M 77.87M N/A N/A
Total Assets 894.03M 830.40M 814.67M 821.15M 883.25M 997.75M 889.07M 873.60M 866.61M 857.33M N/A N/A
Total Debt 297.41M 278.12M 252.06M 263.02M 226.11M 305.68M 36.46M 75.51M 50.71M 54.63M N/A N/A
Cash & Equiv 151.17M 100.59M 76.20M 97.40M 189.71M 317.38M 109.48M 141.59M 158.72M 204.76M N/A N/A
Book Value 337.89M 299.47M 273.14M 263.36M 356.08M 385.49M 547.69M 512.16M 527.75M 562.01M N/A N/A
Return on Equity 0.10 0.09 0.09 -0.09 -0.06 -0.37 0.09 0.04 0.00 0.05 N/A N/A
IMAX News
Team Internet is now firmly in a scaling phase - ICYMI
May 23, 2026 04:38 AM · proactiveinvestors.com
Metals One is a identifier, financier and developer - ICYMI
May 23, 2026 04:01 AM · proactiveinvestors.com
First Phosphate CEO discusses Agnico Eagle’s $94M move into phosphate market - ICYMI
May 23, 2026 01:00 AM · proactiveinvestors.com
OKYO Pharma expands scientific advisory board with cornea expert - ICYMI
May 23, 2026 12:00 AM · proactiveinvestors.com
Ilika advances Goliath commercialisation strategy - ICYMI
May 22, 2026 10:35 PM · proactiveinvestors.com
IMAX has bucked the trend as the movie-theater business fades — here's why it's so attractive to would-be buyers
May 22, 2026 12:38 PM · marketwatch.com
IMAX Might Be Exploring a Sale. Who Could Be Buying.
May 22, 2026 10:35 AM · barrons.com
Tiziana Life Sciences advances foralumab program with full Phase 2 enrollment and encouraging expanded access data – ICYMI
May 22, 2026 08:48 AM · proactiveinvestors.com
Wall Street thinks IMAX is ripe for a sale. Here's who could buy it
May 22, 2026 08:26 AM · cnbc.com
Dow Jones closes at new record high on Iran peace hopes
May 22, 2026 08:05 AM · proactiveinvestors.com